Incident Reporting in Canada: 10-Day and 30-Day Preliminary and Final Reports

1. Key takeaways

Under sections 59 to 61 of the Medical Devices Regulations, manufacturers and importers must each submit preliminary and final reports to the Minister for reportable incidents involving their devices that occur inside Canada. The deadlines are 10 days after becoming aware of an incident that has already caused death or a serious deterioration in a person’s state of health, and 30 days after becoming aware of an incident that has not yet caused death or serious deterioration but could reasonably be expected to do so if it recurred.

• Manufacturers and importers are separate and parallel reporting parties; a report filed by one does not discharge the duty of the other.
• An incident is reportable only when it is associated with a failure of the device, a drop in its effectiveness, or any inadequacy in its labelling or directions for use, together with the death or serious deterioration element or the possible-recurrence element.
• The preliminary report must contain the nine elements listed in section 60(2), covering identifiers, the parties involved, dates, incident details, an initial opinion, the proposed course of action including an investigation, and the schedule for the final report.
• For Class I devices, manufacturers and importers must also report incidents that occur outside Canada, subject to the corrective-action conditions in sections 59(1.1) and 59(2).
• The final report must follow the schedule stated in the preliminary report under section 60(2)(h), which means the schedule is a commitment, not an estimate.
• The new mandatory problem reporting requirements took effect on 2021-06-23.

2. Legal basis

The reporting obligations analysed in this article rest on the provisions of the Medical Devices Regulations and on Health Canada guidance. The table below lists each provision, its date and its source, exactly as relied on in this article.

3. Expert insights

The following observations expand on the points in the reporting regime that are most often missed in day-to-day compliance work. Each insight is anchored in the provisions listed above and introduces no requirement beyond those provisions.

Insight 1: the manufacturer and the importer are “each” a reporting party, not alternatives.

The wording of section 59(1) is that “the manufacturer and the importer … shall each make a preliminary and a final report”. A report filed by one party therefore does not relieve the other party of its own obligation. Where a foreign manufacturer relies on its Canadian importer to handle reporting, the manufacturer remains fully on the hook for its own preliminary and final reports, and vice versa.

Insight 2: the trigger conditions for an incident are built from two parallel elements.

Under section 59(1)(b), an incident must simultaneously satisfy two elements: first, it is associated with a failure of the device, a drop in its effectiveness, or any inadequacy in its labelling or directions for use; second, it has resulted in death or a serious deterioration in the state of health of a patient, user or other person, or its recurrence could reasonably be expected to result in such an outcome. The second branch covers the “near miss that could happen again” scenario, which is frequently missed when companies triage incident records.

Insight 3: the contents of the preliminary report are nine statutory elements.

Under section 60(2), the preliminary report must contain: the name and identifiers of the device, including the identifier of any system, test kit, device group, device family or device group family of which the device is a member; the names and addresses of the reporting party and the related parties and the contact representative; the date on which the party became aware of the incident; details of the incident, including its date and its consequences for the patient or user; the name, address and telephone number of the person making the report, if known; any other device or accessory involved, if known; the initial opinion; the proposed course of action, including an investigation, and the schedule for submitting the final report; and whether the device has previously been the subject of a report, with dates if so. A report missing any element risks being treated as incomplete.

Insight 4: the rules for foreign incidents are tiered by device class.

Under section 59(1.1), the manufacturers and importers of Class I devices also owe a reporting duty for incidents that occur outside Canada. Under section 59(2), that duty is conditional: it arises where the manufacturer has indicated to the regulatory authority of the jurisdiction where the incident occurred that it would take corrective action, or where that authority has required the manufacturer to take corrective action. Under section 60(1)(b), the deadline is as soon as feasible after either of those events occurs. This is a different regime from the fixed 10-day and 30-day clocks that apply to domestic incidents.

Insight 5: the final report timeline is proposed by the company itself in the preliminary report.

Under section 61(1), the final report must be filed according to the schedule established under section 60(2)(h) — that is, the schedule the company itself committed to in its preliminary report. This means the “schedule” entered in the preliminary report is a commitment, not an estimate, and it must be set at a date the company can actually meet.

4. Practical recommendations

• Build an incident-type to deadline decision table: death or serious deterioration already caused → 10 days; recurrence could reasonably be expected to lead to death or serious deterioration → 30 days.
• Establish reporting processes separately for the manufacturer and for the importer; the two processes do not substitute for each other.
• Prepare the preliminary report item by item against the nine elements of section 60(2); a missing element can be treated as an incomplete report.
• Treat the final report schedule stated in the preliminary report as enforceable and resource the investigation accordingly.
• For Class I devices, add a foreign-incident trigger test that asks whether the manufacturer has indicated corrective action to, or been required by, the local regulatory authority.

5. Verification checklist

• □ An incident-type to 10-day / 30-day decision table has been established
• □ Separate reporting processes have been established for the manufacturer and for the importer
• □ The preliminary report template already covers the nine elements of section 60(2)
• □ The final report schedule has been set with enforceability in mind
• □ A foreign-incident trigger test has been established for Class I devices
• □ Proof of submission of the reports has been archived

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the Canadian market. Our team manages Health Canada Medical Device Licence and MDEL applications, prepares risk-classified dossiers, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com